These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 9751506

  • 1. Effect of prenatal exposure to diethylstilbestrol on Müllerian duct development in fetal male mice.
    Visser JA, McLuskey A, Verhoef-Post M, Kramer P, Grootegoed JA, Themmen AP.
    Endocrinology; 1998 Oct; 139(10):4244-51. PubMed ID: 9751506
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential expression of anti-Müllerian hormone (amh) and anti-Müllerian hormone receptor type II (amhrII) in the teleost medaka.
    Klüver N, Pfennig F, Pala I, Storch K, Schlieder M, Froschauer A, Gutzeit HO, Schartl M.
    Dev Dyn; 2007 Jan; 236(1):271-81. PubMed ID: 17075875
    [Abstract] [Full Text] [Related]

  • 5. Different patterns of anti-Müllerian hormone expression, as related to DMRT1, SF-1, WT1, GATA-4, Wnt-4, and Lhx9 expression, in the chick differentiating gonads.
    Oréal E, Mazaud S, Picard JY, Magre S, Carré-Eusèbe D.
    Dev Dyn; 2002 Nov; 225(3):221-32. PubMed ID: 12412004
    [Abstract] [Full Text] [Related]

  • 6. Müllerian duct maintenance in heterotypic organ culture after in vivo exposure to diethylstilbestrol.
    Newbold RR, Suzuki Y, McLachlan JA.
    Endocrinology; 1984 Nov; 115(5):1863-8. PubMed ID: 6489263
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Involvement of insulin-like factor 3 (Insl3) in diethylstilbestrol-induced cryptorchidism.
    Emmen JM, McLuskey A, Adham IM, Engel W, Verhoef-Post M, Themmen AP, Grootegoed JA, Brinkmann AO.
    Endocrinology; 2000 Feb; 141(2):846-9. PubMed ID: 10650968
    [Abstract] [Full Text] [Related]

  • 9. Insensitivity to anti-müllerian hormone due to a mutation in the human anti-müllerian hormone receptor.
    Imbeaud S, Faure E, Lamarre I, Mattéi MG, di Clemente N, Tizard R, Carré-Eusèbe D, Belville C, Tragethon L, Tonkin C, Nelson J, McAuliffe M, Bidart JM, Lababidi A, Josso N, Cate RL, Picard JY.
    Nat Genet; 1995 Dec; 11(4):382-8. PubMed ID: 7493017
    [Abstract] [Full Text] [Related]

  • 10. AMH and AMH receptor defects in persistent Müllerian duct syndrome.
    Josso N, Belville C, di Clemente N, Picard JY.
    Hum Reprod Update; 2005 Dec; 11(4):351-6. PubMed ID: 15878900
    [Abstract] [Full Text] [Related]

  • 11. Anti-Müllerian hormone receptor defect.
    di Clemente N, Belville C.
    Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):599-610. PubMed ID: 17161334
    [Abstract] [Full Text] [Related]

  • 12. [Genetics and molecular pathology of anti-Mullerian hormone and its receptor].
    Picard JY, Belville C.
    J Soc Biol; 2002 Dec; 196(3):217-21. PubMed ID: 12462075
    [Abstract] [Full Text] [Related]

  • 13. [Ingestion of diethylstilbestrol during pregnancy. Its responsibility in the testicular feminization syndrome].
    Chryssicopoulos A, Kondi-Parhitis A, Kairi D, Vasiliadis T, Maragoudakis A.
    Presse Med; 1990 Sep 22; 19(30):1397-400. PubMed ID: 2146621
    [Abstract] [Full Text] [Related]

  • 14. Gene expression change in the Müllerian duct of the mouse fetus exposed to diethylstilbestrol in utero.
    Suzuki A, Urushitani H, Sato T, Kobayashi T, Watanabe H, Ohta Y, Iguchi T.
    Exp Biol Med (Maywood); 2007 Apr 22; 232(4):503-14. PubMed ID: 17392486
    [Abstract] [Full Text] [Related]

  • 15. Genetic studies of the AMH/MIS signaling pathway for Müllerian duct regression.
    Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR.
    Mol Cell Endocrinol; 2003 Dec 15; 211(1-2):15-9. PubMed ID: 14656471
    [Abstract] [Full Text] [Related]

  • 16. Autosomal recessive segregation of a truncating mutation of anti-Müllerian type II receptor in a family affected by the persistent Müllerian duct syndrome contrasts with its dominant negative activity in vitro.
    Messika-Zeitoun L, Gouédard L, Belville C, Dutertre M, Lins L, Imbeaud S, Hughes IA, Picard JY, Josso N, di Clemente N.
    J Clin Endocrinol Metab; 2001 Sep 15; 86(9):4390-7. PubMed ID: 11549681
    [Abstract] [Full Text] [Related]

  • 17. Effect of anti-Mullerian hormone on Sertoli and Leydig cell functions in fetal and immature rats.
    Rouiller-Fabre V, Carmona S, Merhi RA, Cate R, Habert R, Vigier B.
    Endocrinology; 1998 Mar 15; 139(3):1213-20. PubMed ID: 9492056
    [Abstract] [Full Text] [Related]

  • 18. Marsupial anti-Mullerian hormone gene structure, regulatory elements, and expression.
    Pask AJ, Whitworth DJ, Mao CA, Wei KJ, Sankovic N, Graves JA, Shaw G, Renfree MB, Behringer RR.
    Biol Reprod; 2004 Jan 15; 70(1):160-7. PubMed ID: 13679313
    [Abstract] [Full Text] [Related]

  • 19. The in vivo roles of müllerian-inhibiting substance.
    Behringer RR.
    Curr Top Dev Biol; 1994 Jan 15; 29():171-87. PubMed ID: 7828438
    [Abstract] [Full Text] [Related]

  • 20. Estrogen inhibition of Mullerian inhibiting substance in the chick embryo.
    Hutson JM, Ikawa H, Donahoe PK.
    J Pediatr Surg; 1982 Dec 15; 17(6):953-9. PubMed ID: 6897657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.